Evidence map›Paper›PMID 32814809›Full record

ArticleScientific reports2020

Nearest-neighbor amino acids of specificity-determining residues influence the activity of engineered Cre-type recombinases.

Anjali Soni, Martina Augsburg, Frank Buchholz, M Teresa Pisabarro

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Precise excision of HTLV-1 provirus with a designer-recombinase.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Anjali SoniStructural Bioinformatics, BIOTEC, TU Dresden, Tatzberg 47-51, 01307, Dresden, Germany.
Martina AugsburgUniversity Carl Gustav Carus and Medical Faculty, UCC, Medical Systems Biology, TU Dresden, Fetscherstrasse 74, Dresden, Germany.
Frank BuchholzUniversity Carl Gustav Carus and Medical Faculty, UCC, Medical Systems Biology, TU Dresden, Fetscherstrasse 74, Dresden, Germany.
M Teresa PisabarroStructural Bioinformatics, BIOTEC, TU Dresden, Tatzberg 47-51, 01307, Dresden, Germany. maria_teresa.pisabarro@tu-dresden.de.
Technische Universität Dresden · DECenter for Systems Biology Dresden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tyrosine-type site-specific DNA recombinase Cre recombines its target site, loxP, with high activity and specificity without cross-recombining the target sites of highly related recombinases. Understanding how Cre achieves this precision is key to be able to rationally engineer site-specific recombinases (SSRs) for genome editing applications. Previous work has revealed key residues for target site selectivity in the Cre/loxP and the related Dre/rox recombinase systems. However, enzymes in which these residues were changed to the respective counterpart only showed weak activity on the foreign target site. Here, we use molecular modeling and dynamics simulation techniques to comprehensively explore the mechanisms by which these residues determine target recognition in the context of their flanking regions in the protein-DNA interface, and we establish a structure-based rationale for the design of improved recombination activities. Our theoretical models reveal that nearest-neighbors to the specificity-determining residues are important players for enhancing SSR activity on the foreign target site. Based on the established rationale, we design new Cre variants with improved rox recombination activities, which we validate experimentally. Our work provides new insights into the target recognition mechanisms of Cre-like recombinases and represents an important step towards the rational design of SSRs for applied genome engineering.

Indexed as

Recombination, GeneticAmino AcidsAmino Acid SequenceAnimalsBinding SitesDNADNA NucleotidyltransferasesGenetic EngineeringHumansIntegrasesMolecular Docking SimulationMolecular Dynamics SimulationNucleic Acid ConformationProtein BindingProtein DomainsSequence Homology, Amino AcidAmino AcidsCre recombinaseDNADNA NucleotidyltransferasesIntegrasesSite-specific recombinase

Identifiers

PMID32814809
PMCPMC7438526
OpenAlexW3055471601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.